Vir Biotechnology, Inc. VIR Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s free cash flow yield?
- Vir Biotechnology, Inc. (VIR) reported free cash flow yield of -31.4% in Q1 2026.
- How has Vir Biotechnology, Inc.'s free cash flow yield changed year-over-year?
- Vir Biotechnology, Inc.'s free cash flow yield increased by 33.9% year-over-year, from -47.5% to -31.4%.
- What is the long-term trend for Vir Biotechnology, Inc.'s free cash flow yield?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s free cash flow yield has grown at a 53.0% compound annual growth rate (CAGR), from -5.6% to -47.3%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.